◆ NeutralQNTM

Quantum BioPharma Ltd. Announces Filing of Supplement to Management Information Circular Correcting Fractional Share Treatment Under Proposed Share Consolidation and Clarifies MVS Voting Power Threshold

GlobeNewswire Inc.·
Quantum BioPharma Ltd. Announces Filing of Supplement to Management Information Circular Correcting Fractional Share Treatment Under Proposed Share Consolidation and Clarifies MVS Voting Power Threshold

Quantum BioPharma Ltd. filed a supplement to its management information circular ahead of its November 10, 2026 shareholder meeting, correcting the treatment of fractional shares in a proposed consolidation of its class A multiple voting shares and class B subordinate voting shares. The company also clarified that MVS holders' voting power will be capped at 70% if their aggregate voting power would otherwise exceed this threshold due to share cancellations.

Read Full Article at GlobeNewswire Inc. →
← Back to Financial Intelligence